Fingerprint
Dive into the research topics of 'Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
Louis P. Garrison, Deborah Lubeck, Deepa Lalla, Virginia Paton, Amylou Dueck, Edith A. Perez
Research output: Contribution to journal › Article › peer-review
89
Scopus
citations